Radiation induces an antitumour immune response to mouse melanoma

International Journal of Radiation Biology

Volumn 85, Issue 12, 2009, Pages 1126-1136

  Perez, Carmen A ^a   Fu, Allie ^a   Onishko, Halina ^a   Hallahan, Dennis E ^b   Geng, Ling ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antitumour immunity; Calreticulin; Melanoma; Radiation

Indexed keywords

CALRETICULIN; DENDRITIC CELL VACCINE; SMALL INTERFERING RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL LEVEL; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MELANOMA; MELANOMA CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; TUMOR IMMUNITY; VACCINATION;

ANIMALS; CALRETICULIN; CANCER VACCINES; CELL LINE, TUMOR; CELL MEMBRANE; DENDRITIC CELLS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PHAGOCYTOSIS; RADIATION DOSAGE; RNA, SMALL INTERFERING;

MUS;

EID: 72049083994     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903242099     Document Type: Article

References (33)

1. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. The Journal of Experimental Medicine 188(7):1359-1368.
2. Ang KK, Peters LJ, Weber RS, Morrison WH, Frankenthaler, RA, Garden AS, Goepfert H, Ha CS, Byers, RM. 1994. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. International Journal of Radiation Oncology, Biology & Physics 30(4):795-798.
3. Ansari R, Gaber MW, Wang B, Pattillo CB, Miyamoto C, Kiani MF. 2007. Anti-TNFA (TNF-alpha) treatment abrogates radiation-induced changes in vacular density and tissue oxygenation. Radiation Research 167(1):80-86.
4. Brown JM, Attardi LD. 2005. The role of apoptosis in cancer development and treatment response. National Review of Cancer 5(3):231-237.
5. Cao ZA, Daniel D, Hanahan D. 2002. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer 2:11.
6. Chang BK, Timmerman RD. 2007. Stereotactic body radiation therapy: A comprehensive review. American Journal of Clinical Oncology 30(6):637-644.
7. Chiang CS, Hong JH, Wu YC, McBride WH, Dougherty GJ. 2000. Combining radiation therapy with interleukin-3 gene immunotherapy. Cancer Gene Therapy 7(18):1172-1178.
8. Clarke C, Smyth MJ. 2007. Calreticulin exposure increases cancer immunogenicity. Nature Biotechnology 25(2):192-193.
9. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC. 2004. Ionising radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International Journal of Radiation Oncology, Biology & Physics 58(3):862-870.
10. Fonseca C, Dranoff G. 2008. Capitalizing on the immunogenicity of dying tumor cells. Clinical Cancer Research 14(6):1603-1608.
11. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE. 2001. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Research 61(6):2413-2419.
12. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR. 1995. Spatial and temporal control of gene therapy using ionizing radiation. Nature Medicine 1(8):786-791.
13. Hofbauer GF, Baur T, Bonnet MC, Tartour E, Burg G, Berinstein NL, Dummer R. 2008. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colonystimulating factor or interleukin-2: The transgene determines the composition of the inflammatory infiltrate. Melanoma Research 18(2):104-111.
14. Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. 2009. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proceedings of the National Academy of Sciences of the United States of America 106(5):1524-1529.
15. Johansen P, Storni T, Rettig L, Qiu Z, Der-Sarkissian A, Smith KA, Manolova V, Lang KS, Senti G, Müllhaupt B, Gerlach T, Speck RF, Bot A, Kündig TM. 2008. Antigen kinetics determines immune reactivity. Proceedings of the National Academy of Sciences of the United States of America 105(13):5189-5194.
16. Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. 2005. The controversial abscopal effect. Cancer Treatment Reviews 31(13):159-172.
17. Link BK, Ballas ZK, Weisdorf D, Wooldridge JE, Bassler AD, Shannon M, Rosmussen WL, Krieg AM, Weiner GJ. 2006. Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma. Journal of Immunotherapy 29(5):558-568.
18. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. 2005. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. The Journal of Immunology 174(12):7516-7523.
19. Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. 2008. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. The Journal of Immunology 180(5):3132-3139.
20. Majer M, Samlowski WE. 2007. Management of metastatic melanoma patients with brain metastases. Current Oncology Reports 9(5):411-416.
21. Mason KA, Ariga H, Neal R, Valdecanos D, Hunter N, Krieg AM, Whisnant JK, Milas L. 2005. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Clinical Cancer Research 11(1):361-369.
22. Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK. 2004. CpG oligodeoxynucleotide enhances tumor response to radiation. Cancer Research 64(15):5074-5077.
23. Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, van Endert P, Zitvogel L, Kroemer G. 2007a. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death & Differentiation 14(10):1848-1850.
24. Overgaard J, Overgaard M, Hansen PV, von der Maase H. 1986. Some factors of importance in the radiation treatment of malignant melanoma. Radiotherapy & Oncology 5(3):183-192.
25. Overgaard J, von der Maase H, Overgaard M. 1985. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. International Journal of Radiation Oncology, Biology & Physics 11(10):1837-1839.
26. Parmiani G, Castelli C, Santinami M, Rivoltini L. 2007. Melanoma immunology: Past, present and future. Current Opinion in Oncology 19(2):121-127.
27. Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Hafaf DJ, Hellman S, Weichselbaum RR. 2008. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clinical Cancer Research 14(16):5255-5259.
28. Schoenborn JR, Wilson CB. 2007. Regulation of interferongamma during innate and adaptive immune responses. Advanced Immunology 96:41-101.
29. Somosy Z. 2000. Radiation response of cell organelles. Micron 31(2):165-181.
30. Stevens G, McKay MJ. 2006. Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncology 7(7):575-583.
31. Terando AM Faries MB, Morton DL. 2007. Vaccine therapy for melanoma: Current status and future directions. Vaccine 25(Suppl. 2):B4-16.
32. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. 2008. Molecular characteristics of immunogenic cancer cell death. Cell Death & Differentiation 15(1):3-12.
33. Yang G, Wu L, Chen L, Pei B, Wang Y, Zhan F, Wu Y, Yu Z. 2007. Targeted irradiation of shoot apical meristem of Arabidopsis embryos induces long-distance bystander/abscopal effects. Radiation Research 167(3):298-305.